CCR8: Great Expectations
Time: 1:30 pm
day: Conference Day Two
Details:
- CCR8 is emerging as the next hot immuno-oncology target
- DT-7012: discovery of a highly differentiated anti-CCR8 depleting antibody
- DT-7012 is about to enter the clinic
